American Healthcare REIT (NYSE:AHR) Sets New 12-Month High on Analyst Upgrade

American Healthcare REIT, Inc. (NYSE:AHR)’s share price hit a new 52-week high on Monday after Truist Financial raised their price target on the stock from $22.00 to $27.00. Truist Financial currently has a buy rating on the stock. American Healthcare REIT traded as high as $26.42 and last traded at $26.36, with a volume of 70605 shares traded. The stock had previously closed at $25.68.

Several other analysts also recently commented on AHR. Morgan Stanley raised their price objective on shares of American Healthcare REIT from $17.00 to $22.00 and gave the company an “overweight” rating in a research report on Thursday, August 22nd. KeyCorp raised their price objective on shares of American Healthcare REIT from $16.00 to $27.00 and gave the company an “overweight” rating in a research report on Monday, September 16th. JMP Securities raised their price objective on shares of American Healthcare REIT from $18.00 to $30.00 and gave the company a “market outperform” rating in a research report on Friday. Finally, Bank of America lifted their price target on shares of American Healthcare REIT from $19.00 to $27.00 and gave the company a “buy” rating in a report on Tuesday, August 20th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, American Healthcare REIT presently has an average rating of “Moderate Buy” and a consensus target price of $22.50.

Institutional Trading of American Healthcare REIT

A number of large investors have recently made changes to their positions in AHR. Manning & Napier Advisors LLC purchased a new position in shares of American Healthcare REIT during the 2nd quarter worth about $3,317,000. Quadrature Capital Ltd purchased a new stake in American Healthcare REIT in the 1st quarter valued at about $914,000. Centersquare Investment Management LLC purchased a new stake in American Healthcare REIT in the 1st quarter valued at about $63,269,000. Capstone Investment Advisors LLC purchased a new stake in American Healthcare REIT in the 1st quarter valued at about $1,201,000. Finally, Sei Investments Co. purchased a new stake in American Healthcare REIT in the 1st quarter valued at about $2,967,000. 16.68% of the stock is currently owned by institutional investors.

American Healthcare REIT Price Performance

The company has a debt-to-equity ratio of 0.60, a current ratio of 0.29 and a quick ratio of 0.29. The firm’s 50-day simple moving average is $19.44 and its 200-day simple moving average is $16.08.

American Healthcare REIT (NYSE:AHR) last posted its quarterly earnings results on Monday, August 5th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.28). The business had revenue of $504.60 million during the quarter, compared to the consensus estimate of $506.55 million. American Healthcare REIT had a negative net margin of 1.99% and a negative return on equity of 2.20%. The business’s quarterly revenue was up 7.9% on a year-over-year basis. As a group, research analysts expect that American Healthcare REIT, Inc. will post 1.28 earnings per share for the current fiscal year.

American Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 18th. Investors of record on Friday, September 20th will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, September 20th. This represents a $1.00 annualized dividend and a dividend yield of 3.80%.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.